Literature DB >> 29702297

Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center.

Patrick Hoversten1, Fouad Otaki2, David A Katzka3.   

Abstract

Candida infection in the gastrointestinal tract is most studied in immunocompromised patients. Patients without systemic immunodeficiency, however, may have esophageal candidiasis associated with antibiotic or steroid medication use, alcoholic consumption, diabetes mellitus, and esophageal stasis disorders such achalasia or scleroderma esophagus.1-5 This population has not been well studied. We aim to describe demographics, risk factors, and relevant clinical outcomes for patients with Candida esophagitis with an emphasis in systemically immunocompetent patients.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 29702297     DOI: 10.1016/j.cgh.2018.04.035

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  7 in total

Review 1.  Achalasia.

Authors:  Edoardo Savarino; Shobna Bhatia; Sabine Roman; Daniel Sifrim; Jan Tack; Sarah K Thompson; C Prakash Gyawali
Journal:  Nat Rev Dis Primers       Date:  2022-05-05       Impact factor: 52.329

2.  Esophageal Candidiasis in a Non-HIV Patient: A Primary Care Diagnosis.

Authors:  Sofia Rodrigues; Vera Leitão Esteves; Teresa G Martins
Journal:  Cureus       Date:  2022-04-20

Review 3.  Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature.

Authors:  Mika Yamanaka-Takaichi; Soha Ghanian; David A Katzka; Rochelle R Torgerson; Afsaneh Alavi
Journal:  Am J Clin Dermatol       Date:  2022-04-15       Impact factor: 6.233

4.  Variations in the Clinical Course of Patients with Herpes Simplex Virus Esophagitis Based on Immunocompetence and Presence of Underlying Esophageal Disease.

Authors:  Patrick Hoversten; Amrit K Kamboj; Tsung-Teh Wu; David A Katzka
Journal:  Dig Dis Sci       Date:  2019-02-06       Impact factor: 3.487

Review 5.  Diagnosis and Treatment of Esophageal Candidiasis: Current Updates.

Authors:  Abdimajid Ahmed Mohamed; Xin-Liang Lu; Faycal Awaleh Mounmin
Journal:  Can J Gastroenterol Hepatol       Date:  2019-10-20

Review 6.  Candida albicans-The Virulence Factors and Clinical Manifestations of Infection.

Authors:  Jasminka Talapko; Martina Juzbašić; Tatjana Matijević; Emina Pustijanac; Sanja Bekić; Ivan Kotris; Ivana Škrlec
Journal:  J Fungi (Basel)       Date:  2021-01-22

7.  Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis.

Authors:  Hadis Jafarian; Maral Gharaghani; Seyed Saeed Seyedian; Ali Zarei Mahmoudabadi
Journal:  J Clin Lab Anal       Date:  2021-05-14       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.